Cargando…

Abnormal Laboratory Values for Metabolic and Hormonal Syndromes Are Prevalent Among Patients Undergoing Rotator Cuff Repair

PURPOSE: To determine the prevalence of systemic laboratory abnormalities among patients undergoing rotator cuff repair (RCR). METHODS: Patients who underwent RCR at the authors’ institution for 1 year between October 2021 to September 2022 were retrospectively identified. Preoperative laboratory va...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilde, Brandon, Hotaling, James M., Ishikawa, Hiroaki, Joyce, Christopher, Tashjian, Robert, Chalmers, Peter N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300579/
https://www.ncbi.nlm.nih.gov/pubmed/37388879
http://dx.doi.org/10.1016/j.asmr.2023.03.011
Descripción
Sumario:PURPOSE: To determine the prevalence of systemic laboratory abnormalities among patients undergoing rotator cuff repair (RCR). METHODS: Patients who underwent RCR at the authors’ institution for 1 year between October 2021 to September 2022 were retrospectively identified. Preoperative laboratory values, including serum sex hormones, vitamin D, hemoglobin A1C, and a lipid panel, were obtained as part of our routine practice during the study period. Demographics and tear characteristics were compared in patients with laboratory data and those without. For included patients with laboratory data, mean laboratory values and percentage of patients with abnormal laboratory values were recorded. RESULTS: During a 1-year period of time, 135 RCRs were performed, of which preoperative labs were obtained on 105. Of these, 67% were sex hormone deficient, 36% were vitamin D deficient, 45% had an abnormal hemoglobin A1C, and 64% had an abnormal lipid panel. In total 4% had “normal” labs. CONCLUSIONS: In this retrospective study, sex hormone deficiency is highly prevalent among patients undergoing RCR. Nearly all patients undergoing RCR have systemic laboratory abnormalities involving either sex hormone deficiency, vitamin D deficiency, dyslipidemia, and/or prediabetes. LEVEL OF EVIDENCE: Level IV, prognostic case series.